KalVista Shares Jump 38% on Chiesi's $1.9 Billion Acquisition
By EC Assets · Published · Updated
KalVista Pharmaceuticals shares increased significantly aer the announcement of its acquisition by Chiesi Farmaceutici. The acquisition deal is valued at $1.9 billion. This article is intended for informational purposes only. It does not constitute investment advice.
Stay informed
Market commentary, firm news and research from EC Assets — direct to your inbox.